Patents by Inventor Byeong Sun Choi

Byeong Sun Choi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11930201
    Abstract: The present invention includes obtaining block type identification information on a partition of the current macroblock when the current macroblock is intra-mixed specifying a bock type of the current macroblock based on the block type identification information, obtaining an intra prediction mode of the current macroblock according to the block type of the partition of the current macroblock, and predicting the current macroblock using the intra prediction mode and a pixel value of a neighboring block.
    Type: Grant
    Filed: April 18, 2023
    Date of Patent: March 12, 2024
    Assignee: LG ELECTRONICS INC.
    Inventors: Joon Young Park, Seung Wook Park, Jung Sun Kim, Young Hee Choi, Byeong Moon Jeon
  • Patent number: 8835164
    Abstract: Disclosed are a cell line that expresses protein of Seq. No. 1, and a method for screening an anticancer compound of uterine cervical cancer by using the same. The stable cell line that expresses oncoprotein E6 of a human papillomavirus type 16 variant strain is used to determine a difference in amounts of expression of tumor suppressor genes, such as p53, between E6 protein of the reference strain and E6 protein of a variant strain, thereby screening an anticancer compound of uterine cervical cancer, etc. Further, it is possible to develop an anticancer agent of uterine cervical cancer.
    Type: Grant
    Filed: June 7, 2010
    Date of Patent: September 16, 2014
    Assignee: Korea Center for Disease Control and Prevention
    Inventors: Jee Eun Rhee, Dae Ho Jang, Sung Soon Kim, Byeong Sun Choi
  • Publication number: 20110081644
    Abstract: Disclosed are a cell line that expresses protein of Seq. No. 1, and a method for screening an anticancer compound of uterine cervical cancer by using the same. The stable cell line that expresses oncoprotein E6 of a human papillomavirus type 16 variant strain is used to determine a difference in amounts of expression of tumor suppressor genes, such as p53, between E6 protein of the reference strain and E6 protein of a variant strain, thereby screening an anticancer compound of uterine cervical cancer, etc. Further, it is possible to develop an anticancer agent of uterine cervical cancer.
    Type: Application
    Filed: June 7, 2010
    Publication date: April 7, 2011
    Applicant: KOREA CENTER FOR DISEASE CONTROL AND PREVENTION
    Inventors: Jee Eun Rhee, Dae Ho Jang, Sung Soon Kim, Byeong Sun Choi